Datasheet | January 15, 2025

ELEVECTA™ Transient Cell Line

Source: Cytiva
Elevecta

The ELEVECTA™ transient cell line is engineered for speed and simplicity, enabling seamless integration into existing researchers' and technicians' workflows. This off-the-shelf transient cell line offers a flexible solution for the production of viral vectors through any transient transfection method. To further enhance productivity, Cytiva provides the HyClone™ Prime Expression Medium, which is specifically optimized for the ELEVECTA transient cell line. This combination is designed to shorten development timelines and expedite the progression of promising candidates to clinical trials.

As a part of the ELEVECTA cell line portfolio, the transient cell line delivers speed during early development and offers the flexibility to transition to Cytiva's packaging and producer cell lines. This comprehensive portfolio is tailored to address diverse therapeutic needs, giving you a competitive edge in product development.

access the Datasheet!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Drug Discovery Online? Subscribe today.

Subscribe to Drug Discovery Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Drug Discovery Online